Home › Funds › Patient Square Capital LP › ZNTL

Patient Square Capital LP position in ZNTL

ZENTALIS PHARMACEUTICALS INC · Health Care

Patient Square Capital LP reported holding 2,007,485 shares of ZNTL (ZENTALIS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$5.6M, representing 0.89% of its reported portfolio and ranking #21 among its reported holdings. Patient Square Capital LP first reported this position in Q3 2026.

Latest position (Q3 2026)2.01M sh
Reported value held$5.56M
Portfolio Weight0.89%
First reportedQ3 2026
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Square Capital LP's ZNTL position evolved

Patient Square Capital LP first disclosed a stake in ZNTL in Q3 2026 at 2,007,485 shares (US$5.6M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 2.01M $5.56M New

About ZNTL and 13F data

ZNTL (ZENTALIS PHARMACEUTICALS INC) is a Health Care company. 30 other funds we track also report a position in ZNTL — the largest reported positions include 5AM Venture Management, LLC (US$19.1M), Opaleye Management Inc. (US$6.9M), Decheng Capital LLC (US$6.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZNTL

All ZNTL fund holders →

FAQ

How long has Patient Square Capital LP held ZNTL?

Patient Square Capital LP has disclosed ZNTL holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Patient Square Capital LP's current position in ZNTL?

As of Q3 2026, Patient Square Capital LP holds 2.01M shares of ZNTL (ZENTALIS PHARMACEUTICALS INC), valued at $5.56M, representing 0.89% of its reported portfolio and ranking #21.

Has Patient Square Capital LP been buying or selling ZNTL?

In the latest 13F filing (Q3 2026), Patient Square Capital LP newly opened its position in ZNTL.

Which other funds hold ZNTL?

Other major institutional holders of ZNTL include 5AM Venture Management, LLC, Opaleye Management Inc., Decheng Capital LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.